GSK’s Indian Horlicks sale may fetch over $4 billionGlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over Share XGSK’s Indian Horlicks sale may fetch over $4 billionhttps://pharmaphorum.com/news/gsk-indian-horlicks-sell-might-fetch-4-billion/
